108 related articles for article (PubMed ID: 26753664)
1. Microbiological investigation of medication-related osteonecrosis of the jaw: preliminary results.
Crincoli V; Ballini A; Di Comite M; Tettamanti L; Coscia MF; Mastrangelo F; De Vito D
J Biol Regul Homeost Agents; 2015; 29(4):977-83. PubMed ID: 26753664
[TBL] [Abstract][Full Text] [Related]
2. Molecular profiling of oral microbiota in jawbone samples of bisphosphonate-related osteonecrosis of the jaw.
Wei X; Pushalkar S; Estilo C; Wong C; Farooki A; Fornier M; Bohle G; Huryn J; Li Y; Doty S; Saxena D
Oral Dis; 2012 Sep; 18(6):602-12. PubMed ID: 22443347
[TBL] [Abstract][Full Text] [Related]
3. Bacterial diversity in medication-related osteonecrosis of the jaw.
Hallmer F; Bjørnland T; Andersson G; Becktor JP; Kristoffersen AK; Enersen M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Apr; 123(4):436-444. PubMed ID: 28159588
[TBL] [Abstract][Full Text] [Related]
4. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ) patients with sitafloxacin: new strategies for the treatment of BRONJ.
Ikeda T; Kuraguchi J; Kogashiwa Y; Yokoi H; Satomi T; Kohno N
Bone; 2015 Apr; 73():217-22. PubMed ID: 25549869
[TBL] [Abstract][Full Text] [Related]
6. Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?
Lescaille G; Coudert AE; Baaroun V; Javelot MJ; Cohen-Solal M; Berdal A; Goudot P; Azérad J; Ruhin B; Descroix V
J Rheumatol; 2013 Jun; 40(6):781-6. PubMed ID: 23504384
[TBL] [Abstract][Full Text] [Related]
7. Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases.
Di Fede O; Fusco V; Matranga D; Solazzo L; Gabriele M; Gaeta GM; Favia G; Sprini D; Peluso F; Colella G; Vescovi P; Campisi G
Eur J Intern Med; 2013 Dec; 24(8):784-90. PubMed ID: 23768563
[TBL] [Abstract][Full Text] [Related]
8. Histomorphologic characteristics of bisphosphonate-related osteonecrosis of the jaw.
Koerdt S; Dax S; Grimaldi H; Ristow O; Kuebler AC; Reuther T
J Oral Pathol Med; 2014 Jul; 43(6):448-53. PubMed ID: 24456519
[TBL] [Abstract][Full Text] [Related]
9. Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update.
Utreja A; Almas K; Javed F
Odontostomatol Trop; 2013 Jun; 36(142):38-46. PubMed ID: 24073539
[TBL] [Abstract][Full Text] [Related]
10. Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw.
Pushalkar S; Li X; Kurago Z; Ramanathapuram LV; Matsumura S; Fleisher KE; Glickman R; Yan W; Li Y; Saxena D
Int J Oral Sci; 2014 Dec; 6(4):219-26. PubMed ID: 25105817
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate related osteonecrosis of the jaws: clinico-pathological investigation and histomorphometric analysis.
Anavi-Lev K; Anavi Y; Chaushu G; Alon DM; Gal G; Kaplan I
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 May; 115(5):660-6. PubMed ID: 23601221
[TBL] [Abstract][Full Text] [Related]
12. Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases.
Mozzati M; Gallesio G; Arata V; Pol R; Scoletta M
Oral Oncol; 2012 May; 48(5):469-74. PubMed ID: 22265335
[TBL] [Abstract][Full Text] [Related]
13. Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate.
Ulmner M; Jarnbring F; Törring O
J Oral Maxillofac Surg; 2014 Jan; 72(1):76-82. PubMed ID: 23992777
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
Vescovi P; Nammour S
Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
[TBL] [Abstract][Full Text] [Related]
15. Electrically conductive bacterial nanowires in bisphosphonate-related osteonecrosis of the jaw biofilms.
Wanger G; Gorby Y; El-Naggar MY; Yuzvinsky TD; Schaudinn C; Gorur A; Sedghizadeh PP
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jan; 115(1):71-8. PubMed ID: 23217537
[TBL] [Abstract][Full Text] [Related]
16. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
Lazarovici TS; Mesilaty-Gross S; Vered I; Pariente C; Kanety H; Givol N; Yahalom R; Taicher S; Yarom N
J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033
[TBL] [Abstract][Full Text] [Related]
17. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
18. Role of microbiological culture and polymerase chain reaction (PCR) of actinomyces in medication-related osteonecrosis of the jaw (MRONJ).
Panya S; Fliefel R; Probst F; Tröltzsch M; Ehrenfeld M; Schubert S; Otto S
J Craniomaxillofac Surg; 2017 Mar; 45(3):357-363. PubMed ID: 28162845
[TBL] [Abstract][Full Text] [Related]
19. Potential significance of antiestrogen therapy in the development of bisphosphonate related osteonecrosis of the jaw.
Vaszilko M; Kovacs E; Restar L; Balla B; Cseplo K; Kosa J; Lakatos P
J Craniomaxillofac Surg; 2014 Dec; 42(8):1932-6. PubMed ID: 25316650
[TBL] [Abstract][Full Text] [Related]
20. Novel Histopathological Findings of Micro Bone Fragments and Epithelial Response in the Oral Mucosa in Bisphosphonate-Related Osteonecrosis of the Jaw.
Koizumi G; Hayashi A; Takigawa A; Yamada R; Murata T; Shimizu K; Watanabe M; Arai N
J Investig Med High Impact Case Rep; 2024; 12():23247096241258076. PubMed ID: 38818904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
